RCT-TAP-ESP-CSNCT07853482
TAP vs. ESP Blocks for Post-Cesarean Analgesia
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Recruitment opened
- Start date changed from estimate of Oct 15, 2026 to Oct 16, 2026
- Site details revised
- Minor Site contact updated
- Study title shortened, about 4 words
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Secondary (5)
Arms and interventions
Participants receive baseline multimodal analgesia (ketoprofen + paracetamol) PLUS bilateral ultrasound-guided ESP block at L1 level (20 mL of 0.375% ropivacaine per side). No trimeperidine is administered in this group.
Participants receive baseline multimodal analgesia (ketoprofen + paracetamol) PLUS bilateral ultrasound-guided TAP block (20 mL of 0.375% ropivacaine per side). No trimeperidine is administered in this group.
Participants receive baseline multimodal analgesia (ketoprofen + paracetamol) WITHOUT interfascial blocks. Rescue analgesia with trimeperidine 20 mg IM is available if NRS \> 4.
Drugs: Ropivacaine, Ketoprofen and Paracetamol, Trimeperidine (Rescue)
Procedures: Ultrasound-guided Nerve Block, Ultrasound-guided ESP Block, Ultrasound-guided TAP Block
Sites
1 site in 1 country
- Maternity Hospital - State Budgetary Institution of the Rostov Region, TaganrogTaganrog, Rostov Oblast, Russia